RxDoctor Payments Data

Mark Mantell, MD

Vascular Surgery · Philadelphia, PANPI 1104984046

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by ETS Wound Care LLC at 47.0% of the total. Reporting peaked in 2023 at $2,000 and has fallen 98.0% since, to $40 in 2024. That places this record below the midpoint for vascular surgery clinicians in PA, where the typical reported total is $3,795.

$4,257in general payments, 2019–2025

Across 27 payments — averaging $157.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ETS Wound Care LLC$2K
  • Medtronic$1K
  • BD$450
  • Getinge USA Sales, LLC$260
  • Paratek Pharmaceuticals, Inc.$101
  • Baxter Healthcare$40
  • plus $102 from 5 others

What the payments were for

  • Consulting fees$2,00047%
  • Speaking & faculty fees$45011%
  • Travel & lodging$1,00023%
  • Food & beverage$80719%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,257 in reported general payments places this provider in the 50th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$134,655
Medicare patients
276
Services billed
630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone11$7

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →